i&i Biotech Fund

i&i Biotech Fund is a Luxembourg-based venture capital firm established in 2021, specializing in investments in innovative early-stage life science companies. The firm focuses on sectors such as drug discovery, medical devices, diagnostics, and digital health. By targeting European startups, i&i Biotech Fund aims to support the development of cutting-edge technologies and healthcare solutions that can significantly impact patient care and medical advancements.

Karel Kubias

Partner

Tomáš Maršálek

Partner & Chief Financial Officer

Ivan Vohlmuth

Partner

Jaromír Zahrádka

Partner & Chief Executive Officer

Barbora Šumová

Senior Associate

2 past transactions

Delta Diagnostics

Series A in 2023
Delta Diagnostics is a quality oriented diagnostic center established in 1996. It is promoted and operated by a group of doctors all of whom are specialized in different branches of diagnostics. It was promoted with the intention of providing quality diagnostic support at reasonable cost – as we all know, quality cannot be cheap, however, we have proved that it can be provided at a reasonable cost to patients. We have continued to provide the same high level of quality for 19 years.

Sampling Human

Seed Round in 2022
At XENO we believe biology speaks biology best. Many foundational problems in diagnostics and bioengineering are solvable if biology could just do more of the work. But current biotech isn’t smart enough. We are interested in changing the status quo by systematizing biologic units and constructing modular composition rules. We are a team of engineers and biologists with specialized expertise and common system goals.